Related Experiment Video
Updated: Jan 4, 2026
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
13.5K
Evaluating Glaucoma Treatment Effect on Intraocular Pressure Reduction Using Propensity Score Weighted Regression
Mengfei Wu1,2, Mengling Liu3,4, Joel S Schuman1,5
1Department of Ophthalmology, New York University (NYU) School of Medicine, NYU Langone Health, New York, NY, USA.
Scientific Reports
|October 31, 2019
Summary
Propensity score weighting successfully reduced bias in this glaucoma study. All treatments lowered intraocular pressure (IOP), with non-laser surgery (NLS) showing the greatest IOP reduction.
Area of Science:
- Ophthalmology
- Clinical Research
- Biostatistics
Background:
- Observational studies are crucial for evaluating real-world glaucoma treatment effectiveness, particularly combination therapies.
- Selection bias in observational studies can confound treatment effect assessments.
- Propensity score (PS) weighting is a statistical method to mitigate selection bias.
Purpose of the Study:
- To evaluate the 1-year intraocular pressure (IOP) change across five glaucoma treatment strategies.
- To assess the efficacy of medication, laser, non-laser surgery (NLS), laser + medication, and NLS + medication.
- To determine if baseline IOP influences treatment effectiveness.
Main Methods:
- Observational study design involving 90 glaucoma patients.
- Data collection included pre-treatment and 12-month post-treatment IOP measurements.
- Propensity score (PS) weighting was employed to correct for baseline IOP differences across treatment groups.
Main Results:
- Baseline IOP varied significantly across groups (p=0.007) but was successfully balanced using PS weighting (p=0.81).
- All treatment groups demonstrated statistically significant IOP reductions after 1 year.
- Non-laser surgery (NLS) resulted in the largest mean IOP reduction (-6.78 mmHg).
- A significant interaction between baseline IOP and treatment effect was observed (p=0.03), with medication being less effective at high baseline IOP.
Conclusions:
- Glaucoma treatment effectiveness varies by modality and is influenced by baseline intraocular pressure.
- Propensity score weighting is effective in reducing selection bias for valid treatment effect assessment in observational glaucoma studies.
- Non-laser surgery appears to be a highly effective treatment for lowering IOP in glaucoma patients.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
912
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
912
01:25Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
01:28Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K